At Memorial Sloan Kettering Cancer Center, our team of medical professionals has extensive experience in diagnosing and treating pediatric sarcomas, caring for about 140 newly diagnosed children, adolescents, and young adults each year with this disease.
Many of our patients are young adults up to the age of 40 who have been diagnosed with pediatric sarcomas. Our experts routinely treat young patients with types of sarcomas that may be rarely seen by many other healthcare professionals.
Our team of experts – including pediatric oncologists, surgical oncologists, radiation oncologists, diagnostic radiologists, pathologists, integrative medicine specialists, nurses, psychiatrists, and physical therapists – is devoted to delivering compassionate care to every patient diagnosed with pediatric sarcoma. From children to young adults, our experts treat patients as if they were members of their own families.
Patients at Memorial Sloan Kettering are assured the most-comprehensive access to the most-up-to-date therapies available.
Doctors at Memorial Sloan Kettering have spent decades leading many national clinical trials aimed at improving cure rates for pediatric sarcomas. Since the 1970s, physician-scientists at Memorial Sloan Kettering have pioneered the use of combination chemotherapy, which is an essential part of sarcoma treatment today. In fact, treatment regimens developed here now serve as models for the treatment protocols used worldwide.(1)
Our surgeons are leaders in performing procedures that not only completely remove tumors but also preserve the maximum possible function in an affected limbs. For types of tumors that respond well to radiation, our radiologists established the use of intensity-modulated radiation therapy, a technique that targets tumors so efficiently that it leaves surrounding healthy tissue unharmed, even when the cancer is near a vital organ.
Our researchers continue to develop new medical therapies and surgical techniques for the treatment of pediatric sarcomas. The new treatments being developed focus on delivering effective tumor-killing agents while reducing the side effects associated with therapy. These innovations are designed to tailor cancer therapies to each young patient’s individual metabolism and the extent of his or her disease.
Learn more about how we diagnose and treat pediatric sarcomas.